In recent years, the role of Vitamin E supplementation in the prevention of cardiovascular disease (CVD) in the diabetic population has been a topic of interest. 1 A haptoglobin (Hp) gene polymorphism strongly defines the greater risk of vascular disease in individuals with diabetes. Several clinical trials have shown the pharmacogenomic interactions between Hp genotype and Vitamin E and the potential benefits of Vitamin E supplementation reducing CVD in Hp2-2 individuals with diabetes. 2 Reference: Blum S, et al., Atherosclerosis. 2010;211(1):25-27. Hochberg I, et al., Current Diabetes Reports.
2017;17(6). In this exclusive video, Dr. Dwarakanath C.S. sheds light on the Hp gene - Vitamin E interactions and the potential use of Vitamin E supplementation in reducing cardiovascular risk factors in diabetes patients. In the next video, Dr. Vaishali Deshmukh briefs about the haptoglobin…
